Design Therapeutics, Inc.

Design Therapeutics, Inc.

World Rank (Aug-2026)
9579
Market Cap (Aug-2026)
0.928 Billion USD
Market Cap (Mar-08-2026)
0.572 Billion USD
World Rank (Jan-05-2024)
19,654
Market Cap (Jan-05-2024)
0.143 Billion USD
World Rank (Jul-30-2023)
11,986
World Rank (Jan-07-2022)
9,455
Market Cap (Jan-07-2022)
1.000 Billion USD
World Rank (Jan-01-2021)
8,788
Headquarters Country
USA
Nasdaq / NYSE Code
DSGN
Employee Count
38
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Operating Income in USD
-79 Million USD
Annual Net Income in USD
-70 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
226 Million USD
Total Liabilities in USD
14 Million USD
Total Equity in USD
213 Million USD
Balance Sheet for Period Ending
As of December-2025
Yahoo
Yahoo @ Nasdaq
Company Profile
Design Therapeutics, INC is a biotechnology company focused on molecules are designed to selectively bind to genetic repeat sequences, modulate gene expression either by restoring or blocking transcription and restore cellular health. The headquarters is in USA.
IPO Year
2021
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share